Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer.
about
Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal BiomarkersGleason 6 Prostate Cancer: Translating Biology into Population Health.Serum markers in prostate cancer detectionThe Prostate Health Index: Its Utility in Prostate Cancer DetectionBiomarkers for prostate cancer: present challenges and future opportunities.Current biomarkers for diagnosing of prostate cancer.A multiparametric approach to improve upon existing prostate cancer screening and biopsy recommendations.Screening and Detection of Prostate Cancer-Review of Literature and Current Perspective.Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions.Clinical Utility of Biomarkers in Localized Prostate Cancer.Beyond prostate-specific antigen: utilizing novel strategies to screen men for prostate cancer.The role of prostate cancer biomarkers in undiagnosed men.Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone: Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above.Prostate health index significantly reduced unnecessary prostate biopsies in patients with PSA 2-10 ng/mL and PSA >10 ng/mL: Results from a Multicenter Study in China.Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer.Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk.The Prostate Health Index adds predictive value to multi-parametric MRI in detecting significant prostate cancers in a repeat biopsy population.Recommandations de l’Association des urologues du Canada sur le dépistage et le diagnostic précoce du cancer de la prostate.Whom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators.Engaging the primary care community to encourage appropriate prostate cancer screening.Clinical performance of the 4Kscore Test to predict high-grade prostate cancer at biopsy: A meta-analysis of us and European clinical validation study results.Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer.Biomarkers for Prostate Biopsy and Risk Stratification of Newly Diagnosed Prostate Cancer Patients.A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale.Prostatectomy-based validation of combined urine and plasma test for predicting high grade prostate cancer.Prostate-Specific Antigen Trends Predict the Probability of Prostate Cancer in a Very Large U.S. Veterans Affairs Cohort
P2860
Q28075610-DB54EC4B-1E37-4BD8-8A8A-82BA8F994385Q34470640-2F9EE3E0-C157-4A4F-9420-F32197A539AAQ35042519-28AD55B8-0388-47F9-8DFF-BDB2DBF1E1F5Q36328005-B7CE2FE4-AE7A-493F-AB85-7AE5D9DDECDFQ37474443-8D4AF954-DF6B-4441-9BED-34364366D2B8Q38584370-54112BA4-D1BF-40E4-B9B5-AA7EA2639E97Q38725930-71AFC211-66A5-4F25-9B51-39844BB70AF9Q38762709-5818A257-43B8-4C14-BDBE-B6F5A4ED841DQ38786630-37A2A4FA-0221-4F72-983C-554F47654D86Q38792354-2823D2ED-36A6-4210-92EA-D11A62E08721Q38854599-384042D3-87E8-44A1-A04C-7EA97895BDB1Q39140686-79AEE175-C39A-42D9-9F1F-64637BA70EBBQ39331903-A5FF0A15-9C81-4C7F-B8EF-E2A39868792FQ40140207-9550051C-5398-45BE-8B77-98B378E6A956Q40412845-D375E2ED-32EF-4C90-9003-8D995983A5B7Q40888600-0CA948B6-D382-4A5F-9381-F786A93C6ACDQ41474330-23BE167E-4661-45A7-AE76-75CB79F0522AQ47123251-35A3986E-284C-48BA-9A40-413DEEFBBC81Q47436741-A9AF5ACE-FDC8-43B4-9698-B12B95DFF0F4Q47561590-652A641A-84E5-4158-9932-289F52CBAC9DQ47568399-607D4BE6-774C-4A17-B46D-E4466A00FD3FQ47573527-B921B33D-72A5-4CE1-B2B3-4464DCFB5231Q47718669-24652D5C-BCAC-4599-8EBB-59851E1472ACQ47759609-E2CE3FBF-F89D-458E-9861-43B8128F3D92Q48282722-1D4971D3-1DC8-42E4-BB7B-F7F98601029CQ58799069-CEFD9F4C-B879-4290-9B3F-642AA1D1B9D0
P2860
Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Comparison Between the Four-ka ...... or Predicting Prostate Cancer.
@ast
Comparison Between the Four-ka ...... or Predicting Prostate Cancer.
@en
type
label
Comparison Between the Four-ka ...... or Predicting Prostate Cancer.
@ast
Comparison Between the Four-ka ...... or Predicting Prostate Cancer.
@en
prefLabel
Comparison Between the Four-ka ...... or Predicting Prostate Cancer.
@ast
Comparison Between the Four-ka ...... or Predicting Prostate Cancer.
@en
P2093
P2860
P50
P1433
P1476
Comparison Between the Four-ka ...... or Predicting Prostate Cancer.
@en
P2093
Hans Lilja
Martin Eklund
Melissa Assel
P2860
P304
P356
10.1016/J.EURURO.2014.08.010
P407
P577
2014-08-20T00:00:00Z